Successful treatment of Cogan's syndrome with tocilizumab

Scand J Rheumatol. 2021 Jul;50(4):330-331. doi: 10.1080/03009742.2020.1818822. Epub 2020 Oct 13.

Authors

N Kougkas¹, G Bertsias¹, R Stratoudaki², N Avgoustidis¹

Affiliations

¹ Department of Rheumatology, Clinical Immunology and Allergy, University Hospital of Heraklion, Heraklion, Greece.
² ENT, Private Practice, Heraklion, Greece.

PMID: 33047628
DOI: 10.1080/03009742.2020.1818822

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Anti-Inflammatory Agents / therapeutic use*
Antibodies, Monoclonal, Humanized / therapeutic use*
Cogan Syndrome / drug therapy*
Humans
Male
Treatment Outcome

Substances

Anti-Inflammatory Agents
Antibodies, Monoclonal, Humanized
tocilizumab